IL-1β enhances the presence of the granulocytic fraction (CD11b+Ly6G+Ly6Clow) in the initial tumor as well as the monocytic fraction (CD11b+Ly6ChighLy6G−) in metastatic tumors [339]. The gene discussed is IL1B; the disease is neoplasm.